Peter B Crino

University Of Maryland Baltimore

$17,911,903

Attributed

$25,649,475

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.5M · FY2005–25

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$25,649,475 · 15

By mechanism

R01$20,886,262 · 8

R21$1,798,050 · 3

R37$1,418,636 · 1

R43$690,358 · 1

K08$631,169 · 1

R41$225,000 · 1

Top collaborators

Others in their field

Top investigators on “Brain”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
Michael W Weiner · Northern California Institute Res &Educ$149,959,854
David A Bennett · Rush University Medical Center$148,375,056
David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
Walter John Curran · Thomas Jefferson University$114,442,832
Hongkui Zeng · Allen Institute$113,960,965

Research focus

BrainEpilepsyGenesMutationNeuronsSomatic MutationCortical DysplasiaBrain TissueLeadSpecimenPathway InteractionsResectedIntractable EpilepsyPhenotypeCellsAffectSignal TransductionVariantSamplingSeizuresCerebral CortexTissuesMolecularPlay

Grant awards (73)

Identification and molecular characterization of somatic mutations in MCD$642,047

R01 · FY2025 · NS

KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target$326,002

R37 · FY2025 · NS · contact PI

Defining disease mechanisms in SLC35A2 epilepsy$667,685

R01 · FY2024 · NS

Identification and molecular characterization of somatic mutations in MCD$629,401

R01 · FY2024 · NS

Somatic Mutation in Intractable Focal Epilepsy$591,457

R01 · FY2024 · NS

KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target$351,891

R37 · FY2024 · NS · contact PI

Defining disease mechanisms in SLC35A2 epilepsy$148,286

R01 · FY2024 · NS

Identification and molecular characterization of somatic mutations in MCD$720,989

R01 · FY2023 · NS

Defining disease mechanisms in SLC35A2 epilepsy$688,977

R01 · FY2023 · NS

Somatic Mutation in Intractable Focal Epilepsy$616,470

R01 · FY2023 · NS

KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target$363,304

R37 · FY2023 · NS · contact PI

Somatic Mutation in Intractable Focal Epilepsy$82,191

R01 · FY2023 · NS

Somatic Mutation in Intractable Focal Epilepsy$6,206

R01 · FY2023 · NS

Defining disease mechanisms in SLC35A2 epilepsy$688,977

R01 · FY2022 · NS

Somatic Mutation in Intractable Focal Epilepsy$628,091

R01 · FY2022 · NS

KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target$377,439

R37 · FY2022 · NS · contact PI

Defining disease mechanisms in SLC35A2 epilepsy$67,950

R01 · FY2022 · NS

Defining disease mechanisms in SLC35A2 epilepsy$689,617

R01 · FY2021 · NS

Somatic Mutation in Intractable Focal Epilepsy$654,741

R01 · FY2021 · NS

The Role of GATOR1 in Cortical Malformations$339,717

R01 · FY2021 · NS · contact PI

Somatic Mutation in Intractable Focal Epilepsy$733,446

R01 · FY2020 · NS

Defining disease mechanisms in SLC35A2 epilepsy$732,007

R01 · FY2020 · NS

Identification and molecular characterization of somatic mutations in MCD$636,227

R01 · FY2020 · NS

The Role of GATOR1 in Cortical Malformations$339,664

R01 · FY2020 · NS · contact PI

Identification and molecular characterization of somatic mutations in MCD$373,872

R01 · FY2019 · NS

The Role of GATOR1 in Cortical Malformations$342,176

R01 · FY2019 · NS · contact PI

Identification and molecular characterization of somatic mutations in MCD$265,522

R01 · FY2019 · NS

Identification and molecular characterization of somatic mutations in MCD$643,416

R01 · FY2018 · NS

The Role of GATOR1 in Cortical Malformations$343,114

R01 · FY2018 · NS · contact PI

Identification and molecular characterization of somatic mutations in MCD$647,648

R01 · FY2017 · NS

The Role of GATOR1 in Cortical Malformations$342,964

R01 · FY2017 · NS · contact PI

Discovery of Novel Molecular Abnormalities Underlying Non-Lesional Focal Epilepsy$318,924

R01 · FY2017 · NS

Identification and molecular characterization of somatic mutations in MCD$721,689

R01 · FY2016 · NS

Discovery of Novel Molecular Abnormalities Underlying Non-Lesional Focal Epilepsy$319,291

R01 · FY2016 · NS

Detection of Human Papilloma Virus in Cortical Dysplasia$292,245

R01 · FY2016 · NS · contact PI

Detection of Human Papilloma Virus in Cortical Dysplasia$49,005

R01 · FY2016 · NS · contact PI

Using Patient-Derived Neurons for Epilepsy Drug Discovery$389,167

R21 · FY2015 · NS · contact PI

Detection of Human Papilloma Virus in Cortical Dysplasia$341,250

R01 · FY2015 · NS · contact PI

Discovery of Novel Molecular Abnormalities Underlying Non-Lesional Focal Epilepsy$321,453

R01 · FY2015 · NS

mTOR Substrate Phosphorylation: A New Bioassay for Therapeutics$225,000

R41 · FY2015 · NS · contact PI

Discovery of Novel Molecular Abnormalities Underlying Non-lesional Focal Epilepsy$69,526

R01 · FY2015 · NS

Using Patient-Derived Neurons for Epilepsy Drug Discovery$402,806

R21 · FY2014 · NS · contact PI

Discovery of Novel Molecular Abnormalities Underlying Non-Lesional Focal Epilepsy$374,480

R01 · FY2014 · NS

Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures$340,360

R43 · FY2014 · NS

Detection of Human Papilloma Virus in Cortical Dysplasia$337,656

R01 · FY2014 · NS · contact PI

Proof of Principle for a Diagnostic Blood Test of Recurrent Seizures$349,998

R43 · FY2013 · NS

Detection of Human Papilloma Virus in Cortical Dysplasia$331,844

R01 · FY2013 · NS · contact PI

Structural consequences of TSC gene mutations in brain$303,877

R01 · FY2012 · NS · contact PI

Structural consequences of TSC gene mutations in brain$303,877

R01 · FY2011 · NS · contact PI

Structural consequences of TSC gene mutations in brain$306,977

R01 · FY2010 · NS · contact PI

Molecular pathogenesis of focal cortical dysplasias$272,525

R01 · FY2010 · NS · contact PI

Structural consequences of TSC gene mutations in brain$310,078

R01 · FY2009 · NS · contact PI

Molecular pathogenesis of focal cortical dysplasias$275,279

R01 · FY2009 · NS · contact PI

Structural consequences of TSC gene mutations in brain$80,000

R01 · FY2009 · NS · contact PI

Structural consequences of TSC gene mutations in brain$310,078

R01 · FY2008 · NS · contact PI

Molecular pathogenesis of focal cortical dysplasias$275,279

R01 · FY2008 · NS · contact PI

Molecular pathogenesis of focal cortical dysplasias$240,869

R01 · FY2007 · NS · contact PI

Gene Expression Analysis in Tuberous Sclerosis$330,832

R01 · FY2006 · NS · contact PI

Molecular pathogenesis of focal cortical dysplasias$248,063

R01 · FY2006 · NS · contact PI

Gene Expression Analysis in Tuberous Sclerosis$338,794

R01 · FY2005 · NS

Gene Expression Analysis in Tuberous Sclerosis$338,794

R01 · FY2004 · NS

Cellular Proliferation and Epileptogenesis$166,184

R21 · FY2004 · NS

Gene Expression Analysis in Tuberous Sclerosis$188,219

R01 · FY2003 · NS

DEVELOPMENTAL PATHOGENESIS OF HUMAN CORTICAL DYSPLASIA$168,326

K08 · FY2003 · MH

Cellular Proliferation and Epileptogenesis$166,184

R21 · FY2003 · NS

Gene Expression Analysis in Tuberous Sclerosis$22,500

R01 · FY2003 · NS

Cellular Proliferation and Epileptogenesis$209,909

R21 · FY2002 · NS

DEVELOPMENTAL PATHOGENESIS OF HUMAN CORTICAL DYSPLASIA$158,714

K08 · FY2002 · MH

GENE EXPRESSION AND CLONALITY IN DYSPLASTIC CORTICAL NEU$158,500

R21 · FY2002 · NS

DEVELOPMENTAL PATHOGENESIS OF HUMAN CORTICAL DYSPLASIA$154,238

K08 · FY2001 · MH

GENE EXPRESSION AND CLONALITY IN DYSPLASTIC CORTICAL NEU$152,650

R21 · FY2001 · NS

GENE EXPRESSION AND CLONALITY IN DYSPLASTIC CORTICAL NEU$152,650

R21 · FY2000 · NS

DEVELOPMENTAL PATHOGENESIS OF HUMAN CORTICAL DYSPLASIA$149,891

K08 · FY2000 · MH